Diagnostic Test Needed to Identify Drugs Causing Stevens-Johnson Syndrome: Study
A computerized scoring system could more accurately identify medications causing Stevens-Johnson syndrome than doctors can on their own, researchers found.
Tag Archives: Drug Side Effects
-
-
Study Finds Media Coverage Can Increase Drug Prescribing Despite Lack of Scientific Evidence
Rogaine prescribing increased after NYT article, despite a lack of new scientific evidence of benefits.
-
Pentagon Asks Valisure, Not FDA, to Make Sure Drugs for Servicemembers are Safe
The Defense Department is reportedly seeking Valisure's help in ensuring generic drugs, often manufactured overseas and away from FDA influence, given to military service members are safe and effective
-
Diabetes Patients Face Worse Outcomes from Stevens-Johnson Syndrome: Study
Researchers called for doctors to carefully consider a patient's co-morbidity factors when determining their risks from SJS/TEN
-
Preventable Hospital Errors Identified In Nearly 7% Of Admissions in New Study
More than 400,000 patient deaths are attributed to hospital-related adverse events every year, health experts warn
-
FDA Calls for Restrictions on Ovarian Cancer Drug Rubraca Due to High Mortality Rates
If the drug maker Clovis does not update the Rubraca label, the FDA may seek third party recommendations on whether to remove Rubraca from the market
-
Study Highlights Link Between Tepezza and Hearing Problems After Four Injections of the Thyroid Eye Disease Drug
Researchers linked Tepezza and ear toxicity, which led to permanent hearing problems for patients, some of which needed hearing aids
-
Copiktra Side Effects Too Dangerous for Some Cancer Patients, FDA Advisory Committee Decides
Drug experts say the risks of Copiktra side effects likely outweigh the benefits for treatment of certain blood cancers, given the availability of other drugs on the market.
-
FDA Issues New Draft Guidance on Children’s Use in Clinical Trials
Many drugs and medical procedures used on children have never been tested on children in clinical trials for safety and informed consent reasons.
-
Cancer Drug Copiktra Could Shorten Life Expectancy in Some Patients, FDA Reviewers Warn
FDA scientists says a new review of the drug's benefit-risk analysis is warranted.
